CBL Chromosome 11

Cbl proto-oncogene
136 variants 136 Health Risk

Upload your DNA to see your personal genotypes for variants in CBL.

What This Gene Does
This gene is a proto-oncogene that encodes a RING finger E3 ubiquitin ligase. The encoded protein is one of the enzymes required for targeting substrates for degradation by the proteasome. This protein mediates the transfer of ubiquitin from ubiquitin conjugating enzymes (E2) to specific substrates. This protein also contains an N-terminal phosphotyrosine binding domain that allows it to interact with numerous tyrosine-phosphorylated substrates and target them for proteasome degradation. As such it functions as a negative regulator of many signal transduction pathways. This gene has been found to be mutated or translocated in many cancers including acute myeloid leukaemia, and expansion of CGG repeats in the 5' UTR has been associated with Jacobsen syndrome. Mutations in this gene are also the cause of Noonan syndrome-like disorder. [provided by RefSeq, Jul 2016]
Gene Info
Gene Group
Ring finger proteins
Locus Type
gene with protein product
Location
11q23.3
Ensembl
ENSG00000110395
Associated Conditions (26)
RASopathy
CBL-related disorder
Juvenile myelomonocytic leukemia
Cardiovascular phenotype
Noonan syndrome and Noonan-related syndrome
Central nervous system germ cell tumor
Hereditary cancer-predisposing syndrome
Rhabdomyosarcoma
Myeloproliferative disorder
Growth failure in early childhood
Noonan syndrome-like disorder with juvenile myelomonocytic leukemia
Intellectual disability
Noonan syndrome
Inborn genetic diseases
See cases
Hepatosplenomegaly
Epilepsy
early-onset
Pilocytic astrocytoma
Malignant germ cell tumor of ovary
+6 more conditions
Key Variants
All Variants (136)
RSID Category Clinical Significance Conditions
RS767411521 Health Risk Conflicting classifications of pathogenicity RASopathy, Cardiovascular phenotype, RASopathy
RS769151797 Health Risk Conflicting classifications of pathogenicity CBL-related disorder, Juvenile myelomonocytic leukemia, CBL-related disorder
RS769677676 Health Risk Conflicting classifications of pathogenicity RASopathy, RASopathy
RS770667508 Health Risk Conflicting classifications of pathogenicity RASopathy, Cardiovascular phenotype, RASopathy
RS773473702 Health Risk Conflicting classifications of pathogenicity RASopathy, RASopathy
RS773611782 Health Risk Conflicting classifications of pathogenicity RASopathy, Juvenile myelomonocytic leukemia, CBL-related disorder
RS794727972 Health Risk Conflicting classifications of pathogenicity RASopathy, Cardiovascular phenotype, CBL-related disorder
RS878976124 Health Risk Conflicting classifications of pathogenicity Noonan syndrome and Noonan-related syndrome, Noonan syndrome and Noonan-related syndrome
RS886047769 Health Risk Conflicting classifications of pathogenicity CBL-related disorder, Cardiovascular phenotype, RASopathy
RS886047771 Health Risk Conflicting classifications of pathogenicity CBL-related disorder, RASopathy, Cardiovascular phenotype
RS946817829 Health Risk Conflicting classifications of pathogenicity Epilepsy, early-onset, RASopathy
RS949933368 Health Risk Conflicting classifications of pathogenicity Cardiovascular phenotype, RASopathy, CBL-related disorder
RS971746773 Health Risk Conflicting classifications of pathogenicity RASopathy, Cardiovascular phenotype, RASopathy
RS2135301614 Health Risk Likely pathogenic CBL-related disorder, CBL-related disorder
RS2135303545 Health Risk Likely pathogenic RASopathy, RASopathy
RS2135311043 Health Risk Likely pathogenic Noonan syndrome and Noonan-related syndrome, Noonan syndrome and Noonan-related syndrome
RS2496939189 Health Risk Likely pathogenic CBL-related disorder, CBL-related disorder
RS2496939296 Health Risk Likely pathogenic Cardiovascular phenotype, Cardiovascular phenotype
RS267606704 Health Risk Likely pathogenic RASopathy, CBL-related disorder, Inborn genetic diseases
RS387906666 Health Risk Likely pathogenic Juvenile myelomonocytic leukemia, Noonan syndrome-like disorder with juvenile myelomonocytic leukemia, RASopathy
RS727504426 Health Risk Likely pathogenic Noonan syndrome, Juvenile myelomonocytic leukemia, RASopathy
RS768898787 Health Risk Likely pathogenic
RS775272530 Health Risk Likely pathogenic
RS886041500 Health Risk Likely pathogenic Noonan syndrome and Noonan-related syndrome, Noonan syndrome and Noonan-related syndrome
RS1592400784 Health Risk Pathogenic CBL-related disorder, Acute myeloid leukemia, Neoplasm
RS2496939266 Health Risk Pathogenic
RS267606707 Health Risk Pathogenic CBL-related disorder, CBL-related disorder
RS397507489 Health Risk Pathogenic CBL-related disorder, CBL-related disorder
RS397507490 Health Risk Pathogenic RASopathy, RASopathy
RS397507491 Health Risk Pathogenic
RS397507493 Health Risk Pathogenic RASopathy, RASopathy
RS397517076 Health Risk Pathogenic Noonan syndrome, Inborn genetic diseases, Noonan syndrome-like disorder with juvenile myelomonocytic leukemia
RS1555230070 Health Risk Pathogenic/Likely pathogenic CBL-related disorder, CBL-related disorder
RS1949904868 Health Risk Pathogenic/Likely pathogenic Inborn genetic diseases, Inborn genetic diseases
RS267606706 Health Risk Pathogenic/Likely pathogenic Noonan syndrome-like disorder with juvenile myelomonocytic leukemia, RASopathy, See cases
RS397517077 Health Risk Pathogenic/Likely pathogenic CBL-related disorder, RASopathy, Noonan syndrome
« Prev 1 2 3
Sign Up to Analyze Your DNA Log In